Kristina Timdahl, head of clinical development at Swedish Orphan Biovitrum AB (Sobi), has been appointed chief medical officer and head of development at Santhera Pharmaceuticals AG effective January 2017. She will succeed Nick Coppard who is retiring. Dr Timdahl has worked in clinical development roles at Wyeth (now Pfizer Inc) and AstraZeneca Plc. She qualified as a medical doctor at the Karolinska Institutet.
Santhera announced the appointment on 4 October 2016.
Copyright 2016 Evernow Publishing Ltd